OTCPicks.com Daily Market Movers Digest Midday Report for Thursday, November 15th

OTCPicks Publisher Newsletter

OTCPicks.com Daily Market Movers Digest Midday Report for Thursday, November 15th RCON, CALI, CAMH, AMBS, ECOF, DIAAF Our Stocks to Watch today include Recon Technology Ltd. (Nasdaq: RCON), China Auto Logistics Inc. (Nasdaq: CALI), Cambridge Heart Inc. (OTCBB:

CAMH), Amarantus BioSciences Inc. (OTCBB: AMBS), Eco2 Forests Inc. (OTC:

ECOF) and Diamant Art Corp. (OTC: DIAAF).

Visit http://otcpicknews.com/emailmarketer/link.phpM940&N25&L1&F=T to register for our Daily Market Movers Digest Newsletter and Email Stock Watch Alerts.

RECON TECHNOLOGY LIMITED (NASDAQ: RCON) “Up 82.99% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N25&L58&F=T Recon Technology, Ltd. is a non-state-owned oil field service company in China. The company has been providing software, equipment and services designed to increase the efficiency and automation in oil and gas exploration, extraction, production and refinery for Chinese oil and gas fields for more than 10 years.

RCON News:

November 15 – Recon Reports Q1 Fiscal Year 2013 Financial Results Q1 FY `2013 Revenue Up 83%, Net Loss Decreases by 31% Recon Technology, Ltd (Nasdaq: RCON), an oilfield services provider that operates primarily in the People`s Republic of China (the “Company”), today announced its financial results for first quarter fiscal year 2013 ended September 30, 2012.

Q1 FY `13 Highlights * Total revenues for Q1 FY `13 increased by 83.19% to RMB 9.05 million ($1.49 million), due mainly to increased demands of furnaces.

* Gross profits for Q1 FY `13 were RMB2.45 million ($386 thousand),compared to RMB 2.48 million of Q1 FY `12.

* Comprehensive loss attributable to ordinary shareholders for Q1 FY `13 was RMB2.34 million ($370 thousand), a 31.16% decrease from Q1 FY `12.

Diluted losses per share attributable to ordinary shareholders for Q1 FY `13 was RMB0.59 ($0.09), an improvement of 31.39% from diluted losses per share of RMB0.86 in Q1 FY `12.

* Adjust EBITDA in Q1 FY `13 was a loss of RMB1.45 million ($229 thousand), an improvement of 48.26% from Q1 FY `12.

“Our first quarter is usually a slow quarter for our business, but this year revenues have grown early,” said Mr. Yin. Shenping, Recon`s Chief Executive Officer, “Benefited from our good reputation and long-term cooperation with our clients, we achieved more orders from our clients when they launched a new round replacement of furnaces and related accessories.

We will continue our R&D activities to maintain stronger competitiveness and higher margin to secure our business. Besides, our other businesses like automation business and fracturing services, are all progressing smoothly. We will continue to make full use of our advantages and professional experience on oilfield automation and production stimulation-related services to achieve better and faster development.” CHINA AUTO LOGISTIC INCORPORATED (NASDAQ: CALI) “Up 33.02% in morning trading” Detailed Quote: www.otcpicks.com/quotes/CALI.php China Auto Logistics Inc. is one of China`s top sellers of imported luxury vehicles, and also manages China`s largest imported auto mall in Tianjin.

Additionally, it operates www.cali.com.cn, one of the leading automobile portals in China, as well as three major websites serving China`s auto dealers and their customers. The Company also provides a growing variety of “one stop” automobile related services such as short term dealer financing.

CALI News:

November 14 – Luxury Auto Sales Propel 78.3% Increase in China Auto Logistics 2012 Third Quarter Revenues China Auto Logistics Inc. (Nasdaq: CALI), a top seller in China of luxury imported automobiles, a leading provider of auto-related services and developer and operator of one of China`s leading automobile portals and three major auto-related websites, today reported it achieved substantial year over year revenue gains in the three-month and nine-month periods ended September 30, 2012.

Financial Highlights * 2012 third quarter revenues grew 78.3% to $170,456,821 led by an 83.4% increase in Automobile Sales revenues to $168,360,743 and a 22% increase in Financing Services sales to $1,491,170.

* Net income attributable to shareholders in the 2012 third quarter was $1,517,549, or $0.41 per share on 3,693,912 diluted shares outstanding (reflecting the Company`s recent 1 for 6 reverse split). This compared with net income attributable to shareholders in the prior year period of $2,477,747 or $0.68 per share on 3,661,296 diluted shares outstanding. The decline is primarily attributable to a planned decrease in higher margin web-based advertising revenue which was not offset by gains achieved in the Company`s other high margin services businesses, or its lower margin automobile sales.

* In the nine months ended September 30, 2012, revenues grew to $427,950,375, up 41% from the prior year period, led by a 43.2 % year over year increase in Automobile Sales revenues.

* Net income attributable to shareholders in the first nine months of 2012 was $4,748,487or $1.29 per share on 3,693,912 diluted shares outstanding.

This compared with $6,841,081 or $2.04 per share a year earlier on 3,351,414 diluted shares outstanding.

Growth Strategy Mr. Tong Shiping, CEO and Chairman of the Company, stated, “We believe our growth strategy will have increasingly clear benefits over time. In essence, we are sacrificing our web-based advertising revenue and higher profits it might generate in the near term in order to create the opportunities that develop from being a much bigger company and the clear leader in China in luxury auto sales and auto related services. While focusing on the growth of our luxury auto sales we are also exploring opportunities for higher bottom line growth with new services as well as our existing auto-related services. The sharp jump in Auto Sales revenues in this year`s third quarter reflects well on our decision, as does the growth, in particular, of our Financing Services.” Segment Review The largest contributor in the third quarter to the Company`s revenues and profits was its luxury auto sales business. During the quarter the Company sold 2,004 automobiles, up 130% from 871 vehicles in the third quarter of 2011. The average unit price per sale was $84,012 in the 2012 quarter, down from $105,411 per unit in the third quarter last year. The Company continued to price its vehicles very competitively to expand its market share and maintain its leadership position in the industry. The contribution to operating income from Automobile Sales in the 2012 third quarter was $1,124,528 and was $3,777,411 through the first nine months of the year.

Revenues from Financing Services increased 22% year over year in the 2012 third quarter to $1,491,170. In order to provide financing to its customers, on which it earns a service fee, the Company utilizes bank facility lines of credit, provided by some of the leading commercial banks in China. As of September 30, 2012, the Company had approximately $60 million drawn on aggregate lines of approximately $119 million. The contribution to operating income from Financial Services in the quarter was $771,255, up from $426,417 in the same period last year.

As per the Company`s strategic decision, the contribution to operating income from web-based advertising services in the 2012 third quarter was reduced to $109,551 from $1,194,991 a year earlier. Other services businesses which contributed to profits in the quarter were Automobile Value Added Services and Auto Mall Management Services.

Outlook Mr. Tong commented further, “Looking ahead we remain confident that we will maintain our leadership position in the luxury auto sales industry, with continued anticipated support from our automobile portal and websites which are now established in 50 cities throughout China and we intend to extend to 60 cities. Our aim is to capitalize on this leadership position with an expansion of our current high margin services and the addition of new ones.

Underlying our growth strategy is our belief that growth rates for the high-end automobile market in China will continue to exceed those of the mainstream auto market, a view that is shared by several market forecasters.” CAMBRIDGE HEART INCORPORATED (OTCBB: CAMH) “Up 125.23% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N25&L15&F=T Cambridge Heart develops and commercializes non-invasive diagnostic tests for cardiac disease, with a focus on identifying those at risk for sudden cardiac arrest (SCA). The Company`s products incorporate proprietary Microvolt T-Wave Alternans (MTWA) measurement technologies, including the patented Analytic Spectral Method and ultrasensitive disposable electrode sensors. The Company`s MTWA test, originally based on research conducted at the Massachusetts Institute of Technology, is reimbursed by Medicare under its National Coverage Policy. Cambridge Heart, founded in 1990, is based in Tewksbury, MA.

CAMH News:

November 14 – Cambridge Heart Reports Results for the Three and Nine Months Ended September 30, 2012 Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today reported results for the three and nine months ended September 30, 2012. Full financial statements and corresponding commentary can be found in the Company`s Form 10-Q, which will be filed with the Securities and Exchange Commission on November 14, 2012.

Using innovative technologies, Cambridge Heart addresses a key problem in cardiac diagnosis — the identification of those at risk of sudden cardiac death. Sudden cardiac arrest (SCA) accounts for approximately one third of all cardiac deaths, or approximately 300,000 deaths, in the United States each year — more than lung cancer, breast cancer and HIV/AIDS combined.

Out-of-hospital survival is less than 8%, making prediction and prevention critically important. It is estimated that there are approximately 10 to 12 million heart attack and heart failure patients in the U.S. who can benefit from annual Microvolt T-Wave Alternans (MTWA) testing. MTWA is a marker of SCA risk which is measured during a non-invasive treadmill test using Cambridge Heart`s proprietary technologies. The Company`s MTWA test is the only one of its kind that is reimbursed by Medicare under a National Coverage Policy.

As previously announced, the Company has retained the services of Benning Associates, LLC to assist in exploring the Company`s strategic alternatives. The Company also announced that it restructured its operations in order to reduce its cash burn. The restructuring included significant reductions in personnel and overhead costs across all functions of the Company. At September 30, 2012, the Company`s cash balance was $75,000. If the Company is unable to generate adequate cash flows or obtain sufficient additional funding, it will have to further cut back its operations, sell some or all of our assets, license potentially valuable technologies to third parties, and/or cease some or all of its operations.

Commenting on the results of the third quarter and recent events, Cambridge Heart CEO Ali Haghighi-Mood said, “On a sequential basis, our revenue in the third quarter declined by 9% compared to the previous quarter. The decline in revenue and reduction in expenses in the third quarter were a reflection of the restructuring of our operations that we announced in July.” Mr. Haghighi-Mood added, “In regards to exploring the Company`s strategic alternatives, we continue to push the process forward and we`ll provide an update as events develop.” Financial Results for the Three Months ended September 30, 2012 Total revenue for the third quarter ended September 30, 2012 was $419,000, compared to total revenue of $475,000 reported during the same period of 2011. The decrease in revenue compared to the same period in 2011 is largely attributable to the reduction in force effective in July 2012, which impacted all functions of the Company including our direct sales force.

Cost of sales for the third quarter of 2012 was $288,000, compared to $343,000 in the same period in 2011. Gross profit, as a percent of revenue, for the three months ended September 30, 2012 and 2011 was 31% and 28%, respectively. The increase in gross profit is mostly due to selling inventory previously written-off as excess inventory.

Operating expenses for the third quarter of 2012 were $885,000, a decrease of $540,000, or 38%, compared to $1,425,000 in the third quarter of 2011.

The decrease in operating expense is a direct result of the restructuring of the operations announced in July, which impacted all functions of the Company.

The operating loss for the third quarter of 2012 was $754,000 compared to an operating loss of $1,293,000 for the same period last year. Included in the operating loss for the third quarter of 2012 was $122,000 of non-cash stock-based compensation expense, compared to $83,000 in the comparable 2011 period. The increase in non-cash stock-based compensation expense is due to the acceleration of expense recognition of certain stock options in which the service period ended while the stock options continue to become exercisable in accordance with the terms of the stock options. The net loss for the quarter was $1,080,000, or $0.01 per share, compared to a net loss of $1,295,000, or $0.01 per share, in the comparable 2011 period.

Financial Results for the Nine Months ended September 30, 2012 Total revenue for the nine months ended September 30, 2012 was $1,435,000, compared to total revenue of $1,654,000 reported during the same period of 2011.

Cost of sales for the nine months ended September 30, 2012 was $1,215,000, compared to $1,201,000 in the same period in 2011. Gross profit, as a percent of revenue, for the nine months ended September 30, 2012 and 2011 was 15% and 27%, respectively.

Operating expenses for the nine-month periods ended September 30, 2012 and 2011 were $4,090,000 and $4,471,000, respectively.

The operating loss for the nine months ended September 30, 2012 was $3,870,000 compared to an operating loss of $4,018,000 for the same period last year. Included in the operating loss for the nine-month periods of 2012 and 2011 was $349,000 and $273,000, respectively, of non-cash stock-based compensation expense. The net loss for the 2012 period was $4,232,000, or $0.04 per share, compared to a net loss of $4,025,000, or $0.04 per share, in the comparable 2011 period.

The Company ended the third quarter with unrestricted cash and cash equivalents of $75,000. The cash used by operations was $3,361,000 for the nine months ended September 30, 2012, compared to $3,535,697 for the same period in 2011. The Company believes that its existing resources, including cash at September 30, 2012 of $75,000 and the proceeds from the sale of senior secured promissory notes in October 2012 of $150,000, coupled with the currently projected financial results are sufficient to fund operations through the end of November 2012.

As of September 30, 2012, the Company had a total of 124 million shares of common stock and common stock equivalents issued and outstanding, including the effect of converting the Series C-1 preferred stock and the Series D preferred stock into shares of common stock. In addition, there are options and warrants outstanding to purchase 61.0 million shares of common stock, bringing the fully diluted share count to 185 million shares of common stock.

Questions can be directed to the Company`s management or its investor relations firm at the contact numbers provided.

AMARANTUS BIOSCIENCES INCORPORATED (OTCBB: AMBS) “Up 17.95% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N25&L59&F=T Amarantus BioSciences, Inc. is a California-based development-stage biotechnology company founded in January 2008. The Company has a focus on developing certain biologics surrounding the intellectual property and proprietary technologies it owns to treat Parkinsons disease and other human diseases. The Company owns the intellectual property rights to a therapeutic protein known as Mesencephalic-Astrocyte-derived Neurotrophic Factor (“MANF“).

AMBS News:

November 15 – Amarantus BioSciences to Present at CNS Summit 2012 Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing new treatments and diagnostics for Parkinson`s disease and Traumatic Brain Injury centered on its proprietary anti-apoptosis therapeutic protein MANF, announced that Chief Scientific Officer John W.

Commissiong, PhD has been invited to make a presentation to discuss “MANF as therapeutic for Parkinson`s disease” at the Scientific Session of the CNS Summit 2012 in Boca Raton, FL on November 19th, 2012. CNS Summit 2012 is a community that has come together with the goal of collaborating and innovating to bring new treatments to patients suffering from brain disorders.

In addition, President & CEO Gerald E. Commissiong expects to update shareholders regarding corporate development plans and strategies going forward for Amarantus following the release of the Company`s quarterly financial report, expected early next week.

ECO2 FORESTS INCORPORATED (OTC: ECOF) “Up 150.00% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N25&L94&F=T Eco2 Forests, Inc. creates sustainable and renewable resource forests. It focuses on the development of Global Forestry Plan to create various plantations targeted at the rehabilitation of deforested lands and afforestation of previously barren land. Eco2 Forests, Inc. was formerly known as New Carbon Forests, Inc. and changed its name to Eco2 Forests, Inc. in September 2009. The company was incorporated in 2007 and is headquartered in Sacramento, California.

ECOF News:

No recent news for Eco2 Forests, Inc. (OTC: ECOF).

DIAMANT ART CORPORATION (OTCBB: DIAAF) “Up 37.04% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N25&L21&F=T Diamant Art Corporation, through its subsidiaries, provides product management and security solutions. The companys products are used in people management, energy management, work shift planning, work shift and task management, RFID employee management, proof of authentic purchase, and people counting. Its products help retail chains, museums, airports, convention centers, hotels, casinos, museums, and department stores increase productivity and performance. Diamant Art Corporation offers its solutions for various industries, including airports, shopping centers, retail chains, department stores, hotels, constructions sites, casinos, stadiums and arenas, convention centers, and museums. The company was formerly known as ART International Corporation. Diamant Art Corporation was founded in 1986 and is based in Markham, Canada.

DIAAF News:

No recent news for Diamant Art Corporation (OTC: DIAAF).

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company`s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company`s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company`s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://otcpicknews.com/emailmarketer/link.phpM940&N25&L=7&F=T and FINRA at http://otcpicknews.com/emailmarketer/link.phpM940&N25&L=8&F=T.

Disclosure: OTCPicks.com is not currently being compensated by any of the companies covered in this release.

Related posts:

1. OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, November 14th
2. OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, September 12th
3. OTCPicks.com Stocks to Watch for Tuesday, September 25th
4. OTCPicks.com Daily Market Movers Digest Midday Report for Monday, October 22nd
5. OTCPicks.com Daily Market Movers Digest Midday Report for Monday, November 12th